These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10517497)

  • 81. Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function.
    Craiu A; Saito Y; Limon A; Eppich HM; Olson DP; Rodrigues N; Adams GB; Dombkowski D; Richardson P; Schlossman R; Choi PS; Grogins J; O'Connor PG; Cohen K; Attar EC; Freshman J; Rich R; Mangano JA; Gribben JG; Anderson KC; Scadden DT
    Blood; 2005 Mar; 105(5):2235-8. PubMed ID: 15292069
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ex vivo expansion of mafosfamide-purged PBPC products.
    McNiece I; Civin C; Harrington J; Kellner J; Malehorn M; Turney J; Barber J; Jones R
    Cytotherapy; 2006; 8(5):459-64. PubMed ID: 17050250
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells.
    Arboscello E; Botta M; Romero D; Schenone E; Mencoboni M; Bogliolo G; Pannacciulli I
    Anticancer Res; 2001; 21(2A):1139-43. PubMed ID: 11396153
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1561-4. PubMed ID: 6090362
    [TBL] [Abstract][Full Text] [Related]  

  • 85. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.
    Shpall EJ; Stemmer SM; Bearman SI; Myers S; Purdy M; Jones RB
    Breast Cancer Res Treat; 1993; 26 Suppl():S19-23. PubMed ID: 7691269
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas.
    Knauf WU; Koenigsmann MP; Notter M; Hoppe B; Reufi B; Oberberg D; Thiel E; Berdel WE
    Leuk Lymphoma; 1996 Oct; 23(3-4):305-11. PubMed ID: 9031111
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differential phthalocyanine photosensitization of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation.
    Singer CR; Linch DC; Bown SG; Huehns ER; Goldstone AH
    Br J Haematol; 1988 Apr; 68(4):417-22. PubMed ID: 3288271
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies.
    Capizzi R
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):2-17. PubMed ID: 8783661
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia.
    Okamoto S; Olson AC; Berdel WE; Vogler WR
    Blood; 1988 Nov; 72(5):1777-83. PubMed ID: 3052629
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Purging of peripheral blood progenitor cells.
    Brugger W; Scheding S; Vogel W; Kanz L
    Ann Oncol; 1996; 7 Suppl 2():11-3. PubMed ID: 8805943
    [No Abstract]   [Full Text] [Related]  

  • 92. Stem cell manipulation: why and how performing peripheral blood progenitor cell purging.
    Rizzoli V; Carlo-Stella C
    Crit Rev Oncol Hematol; 1997 Jul; 26(2):101-15. PubMed ID: 9298327
    [No Abstract]   [Full Text] [Related]  

  • 93. WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.
    Alberts DS; Speicher LA; Krutzsch M; Wymer J; Capizzi RL; Conlon J; Barrett A; Aickin M
    Eur J Cancer; 1996; 32A Suppl 4():S17-20. PubMed ID: 8976817
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds.
    Guest I; Uetrecht J
    Exp Hematol; 2001 Feb; 29(2):123-37. PubMed ID: 11166451
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples.
    Olm F; Urbansky A; Dykes JH; Laurell T; Scheding S
    Sci Rep; 2019 Jun; 9(1):8777. PubMed ID: 31217534
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oncolytic virotherapy for hematological malignancies.
    Bais S; Bartee E; Rahman MM; McFadden G; Cogle CR
    Adv Virol; 2012; 2012():186512. PubMed ID: 22312362
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.
    Nahimana A; Aubry D; Lagopoulos L; Greaney P; Attinger A; Demotz S; Dawson KM; Schapira M; Tschopp J; Dupuis M; Duchosal MA
    Blood Cancer J; 2011 Dec; 1(12):e47. PubMed ID: 22829095
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A novel mode of stimulating platelet formation activity in megakaryocytes with peanut skin extract.
    Sato T; Akiyama M; Nakahama KI; Seo S; Watanabe M; Tatsuzaki J; Morita I
    J Nat Med; 2018 Jan; 72(1):211-219. PubMed ID: 29019067
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of stem cells in cancer therapy and cancer stem cells: a review.
    Sagar J; Chaib B; Sales K; Winslet M; Seifalian A
    Cancer Cell Int; 2007 Jun; 7():9. PubMed ID: 17547749
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery.
    Poloni A; Leoni P; Curzi L; Cantori I; Mancini S; Montanari M; Masia MC; Olivieri A
    Exp Hematol; 1999 Oct; 27(10):1548-56. PubMed ID: 10517497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.